Home

British pharmaceutical giant GlaxoSmithKline withheld from US drug safety regulators information about the possible dangers of top-selling diabetes drug Avandia, a report in the US press said Tuesday. The allegation was made in the Wall Street Journal on the day that Food and Drug Administration (FDA) experts began a two-day meeting about the risks associated with Avandia and whether the ...

British pharmaceutical giant GlaxoSmithKline withheld from US drug safety regulators information about the possible dangers of top-selling diabetes drug Avandia, a report in the US press said Tuesday. The allegation was made in the Wall Street Journal on the day that Food and Drug Administration (FDA) experts began a two-day meeting about the risks associated with Avandia and whether the ...

WASHINGTON (Reuters) - A heated three-year safety debate about a GlaxoSmithKline Plc diabetes pill reaches a climax this week as opponents and backers face off at a U.S. meeting that will help decide the drug's fate. A panel of scientific experts meets later Tuesday and again Wednesday to consider if Avandia is too dangerous to stay on the market ...

What if my blood sugar's too high today? Is it time for my blood pressure pill? With nagging text messages or more customized two-way interactions, researchers are trying to harness the power of cell phones to help fight chronic diseases. "I call it medical minutes," says Dr. Richard Katz of George Washington University Hospital in the nation's capital ...